Diabetic Angiopathies: Clinical Trials

1,728 trials for Diabetic Angiopathies, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

870 completed, 324 unknown, 183 recruiting, 134 terminated. 723 Not applicable, 231 Phase 2, 144 Phase 3, 134 Phase 1, 108 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable723Completed 346, Unknown 130, Recruiting 98, Terminated 58, Not yet recruiting 38, Active not recruiting 24, Withdrawn 22, Enrolling by invitation 5, Suspended 2
Phase 2231Completed 134, Unknown 38, Terminated 23, Recruiting 15, Active not recruiting 7, Withdrawn 7, Not yet recruiting 6, Enrolling by invitation 1
Phase 3144Completed 79, Terminated 27, Unknown 17, Recruiting 7, Not yet recruiting 5, Withdrawn 5, Active not recruiting 4
Phase 1134Completed 66, Unknown 34, Recruiting 10, Terminated 10, Active not recruiting 6, Not yet recruiting 4, Withdrawn 3, Suspended 1
Phase 4108Completed 56, Unknown 21, Recruiting 9, Terminated 8, Withdrawn 6, Not yet recruiting 4, Active not recruiting 2, Enrolling by invitation 2
Early Phase 120Unknown 8, Completed 6, Not yet recruiting 2, Recruiting 2, Enrolling by invitation 1, Withdrawn 1

Follow Diabetic Angiopathies: new trials by email Literature Review of Diabetic Angiopathies trials Research Report on Diabetic Angiopathies

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
On the Move: Center and Home-Based Exercise to Enhance Mobility in Diabetic Foot Ulcer Recovery
12-week exercise regimen, 12-week standard of care - Diabetic Foot Ulcer
Not applicableNot yet recruitingUniversity of Maryland, Baltimore602027-06-012026-10-07
Eye Health Intervention Study in Upper Manhattan
Intervention, Usual Care - Glaucoma, Suspect, Diabetic Retinopathy
Not applicableWithdrawnColumbia University2027-04-012026-05-29
Subcutaneous Dexpanthenol Administration and Wound Epithelialization
Dexpanthenol, Standard Wound Care - Chronic Wounds, Diabetic Foot Ulcer
Not applicableNot yet recruitingDilara CANBAY OZDEMIR402026-12-022026-10-22
Clinical Efficacy of Modified Simiao Yongan Decoction and Endovascular Therapy for Diabetic Foot Ulcers
Modified Simiao Yongan Decoction, Endovascular Therapy and Standard Care - Diabetic Foot Ulcer, Damp-Heat Toxins Accumulation Syndrome
Not applicableNot yet recruitingChengdu University of Traditional Chinese Medicine1202026-12-012026-09-08
18F-FDG PET/CT for Diagnosis of Diabetic Foot Osteomyelitis
18F-FDG PET/CT - Diabetic Foot Infections
Not yet recruitingJewish General Hospital1502026-11-012026-09-18
Systemic Biochemical Signature and Functional Quality Index of Calcaneal Bone Marrow Aspirate in Adults Undergoing Foot or Ankle Surgery
Diabetic Foot Ulcer, Wound Healing
RecruitingUniversidade Sao Francisco402026-10-212026-10-22
Seltoplasmid Plus Revascularization for Diabetic Infrapopliteal Chronic Limb-Threatening Ischemia
Lower-Extremity Revascularization, Donaperminogene Seltoplasmid - Chronic Limb-Threatening Ischemia, Diabetic Foot Ulcer
Phase 4Not yet recruitingFirst Affiliated Hospital of Wenzhou Medical University1802026-10-202026-09-18
Phase 3 Study of Intravitreal OLN324 in Adults With Diabetic Macular Edema (DME) (OLN324-CP-02)
OLN324, Aflibercept - Diabetic Macular Edema (DME)
Phase 3Not yet recruitingOllin Biosciences, Inc.4502026-10-152026-09-25
Phase 3 Study of Intravitreal OLN324 in Adults With Diabetic Macular Edema (DME) (OLN324-CP-03)
OLN324, Aflibercept - Diabetic Macular Edema (DME)
Phase 3Not yet recruitingOllin Biosciences, Inc.4502026-10-152026-09-25
a Prospective, Multicenter, Randomized Controlled Trial, With a Non-randomized Sentinel Cohort, Evaluating the Efficacy of Bioxheal, a Single-layer Placental-derived Biologic in Nonhealing Diabetic Foot Ulcers
Standard of Care, BIOxHEAL (human amniotic membrane allograft) - Diabetic Foot Ulcer, Amniotic Membrane Placental Allograft
Phase 3RecruitingApplied Biologics, LLC2532026-10-082026-10-16
A Multicenter Randomized Double-Blind Trial of Chrocare CDSS for Integrated Management of Type 2 Diabetes
AI large language model-based clinical decision support system, Standard diabetes integrated management formulated by endocrinologists - Type 2 Diabetes (T2DM), Diabetic Nephropathies
Not applicableNot yet recruitingShanghai Jiao Tong University School of Medicine12002026-10-082026-09-22
Activity Reduction vs Advice for Plantar Hotspots in Diabetes
Individualized Objectively Monitored Activity Reduction, Standard Activity-Reduction Advice - Diabetic Foot, Diabetic Peripheral Neuropathy
Not applicableNot yet recruitingShifa International Hospital1002026-10-012026-09-25
Screening for Diabetic RETINopathy Using a Non-mydriatic Retinograph Funduscope in Occupational MEDicine
Non-mydriatic retinography, Self-administered questionnaire - Diabetic Retinopathy
Not applicableNot yet recruitingUniversity Hospital, Clermont-Ferrand4002026-10-012026-09-18
Placental Cells for Diabetic Foot Ulcers
Placenta Stem Cells - Diabetic Foot Ulcer
Phase 1Not yet recruitingWake Forest University Health Sciences122026-10-012026-07-07
Leveraging Artificial Intelligence to Prevent Vision Loss From Diabetes
AI-BRIDGE, Educational Materials - Diabetic Retinopathy, Diabetes Mellitus
Not applicableRecruitingUniversity of Wisconsin, Madison69002026-10-012026-10-22
Evaluating the Effect of Adipose Tissue Processed With the SyntrFuge™ System in the Healing of Diabetic Foot Ulcers
Syntrfuge Microfragmented Fat, Standard of Care - Diabetic Foot Ulcer
Not applicableNot yet recruitingSyntr Health Technologies, Inc.622026-09-302026-08-21
Randomized, Controlled Study to Investigate the 12-month Efficacy and Safety of Resveratrol Vitamin Supplements in Patients With Non-proliferative Diabetic Retinopathy Without Center Involved Diabetic Macular Edema (REVOLUTION Study)
Resveratrol-Containing Vitamin Supplement - Diabetic Retinopathy, Non Proliferative Diabetic Retinopathy
Phase 4CompletedUniversity of Athens1002026-09-302026-10-09
A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-005)
MK-8748, Aflibercept - Diabetic Retinopathy, Macular Edema
Phase 3RecruitingMerck Sharp & Dohme LLC11042026-09-252026-10-20
Nutritional Status in Adults With Diabetic Foot Ulcers
Protein supplementation and nutrition education - Diabetic Foot Ulcers (DFU), Nutrition Assessment
Not yet recruitingHvidovre University Hospital302026-09-212026-09-18
Effect of Digital-Supported Foot Care Education in Individuals With Type 2 Diabetes
Digital-Supported Foot Care Education - Type 2 Diabetes Mellitus (T2DM)
Not applicableNot yet recruitingSiirt University902026-09-202026-09-10

Showing 20 of 1728. Sign in to see all of them.

Narrower conditions

Diabetic Foot (1030)  ·  Diabetic Retinopathy (682)  ·  Diabetes Mellitus (353)  ·  Foot Ulcer (110)  ·  Macular Degeneration (95)  ·  Diabetes Mellitus, Type 2 (90)  ·  Macular Edema (75)  ·  Varicose Ulcer (74)  ·  Diabetes Complications (64)  ·  Ulcer (61)  ·  Diabetic Neuropathies (57)  ·  Retinal Diseases (55)  ·  Wounds and Injuries (54)  ·  Pressure Ulcer (53)  ·  Leg Ulcer (41)

Broader conditions

Endocrine System Diseases (1723)  ·  Cardiovascular Diseases (1721)  ·  Vascular Diseases (1719)  ·  Diabetes Complications (1664)  ·  Diabetes Mellitus (1375)  ·  Skin and Connective Tissue Diseases (1031)  ·  Skin Diseases (1026)  ·  Skin Ulcer (1012)  ·  Leg Ulcer (989)  ·  Diabetic Neuropathies (981)  ·  Foot Ulcer (920)  ·  Eye Diseases (661)  ·  Retinal Diseases (628)  ·  Nutritional and Metabolic Diseases (446)

Interventions

Standard of Care (92)  ·  aflibercept (45)  ·  Ranibizumab (38)  ·  Bevacizumab (29)  ·  salicylhydroxamic acid (16)  ·  Bandages (15)  ·  Tomography, Optical Coherence (15)  ·  Triamcinolone Acetonide (14)  ·  Negative-Pressure Wound Therapy (11)  ·  Educational Status (10)  ·  Sodium Chloride (10)  ·  Control Groups (9)  ·  Calcium Dobesilate (8)  ·  Debridement (8)  ·  Dexamethasone (8)

Sponsors

National Eye Institute (NEI) (25)  ·  Association for Innovation and Biomedical Research on Light and Image (16)  ·  University of Texas Southwestern Medical Center (16)  ·  Assiut University (15)  ·  Universidad Complutense de Madrid (14)  ·  Integra LifeSciences Corporation (13)  ·  University of Sao Paulo (13)  ·  Cairo University (11)  ·  Novartis Pharmaceuticals (11)  ·  Anterogen Co., Ltd. (10)  ·  Johns Hopkins University (10)  ·  Assistance Publique - Hôpitaux de Paris (9)  ·  Healthpoint (9)  ·  Jaeb Center for Health Research (9)  ·  MiMedx Group, Inc. (9)

Countries

United States (608)  ·  China (112)  ·  United Kingdom (95)  ·  France (78)  ·  Spain (64)  ·  Italy (58)  ·  Germany (57)  ·  Canada (56)  ·  Turkey (Türkiye) (55)  ·  Egypt (49)  ·  Denmark (47)  ·  Brazil (37)  ·  Taiwan (36)  ·  Israel (32)  ·  Mexico (30)

Top investigators

Herbert B Slade, MD (7)  ·  David Armstrong, DPM, MD, PhD (6)  ·  Lawrence Lavery, DPM MPH (5)  ·  Chandan K Sen, PhD (4)  ·  Lawrence Lavery, DPM (4)  ·  Maria B Grant, MD (4)  ·  Pablo Velazquez-Martin, MD (4)  ·  Windy Cole, DPM (4)  ·  Charles M Zelen, DPM (3)

Results publications

PMID 26089210, PMID 28614678, PMID 16291066, PMID 21571677, PMID 23958264, PMID 24767584, PMID 25439614, PMID 26738255, PMID 27269974, PMID 34187716, PMID 35534614, PMID 37260074, PMID 10693087, PMID 10720604, PMID 11319655, PMID 11926784, PMID 12589096, PMID 15353531, PMID 15793206, PMID 16291063, PMID 16389125, PMID 16758177, PMID 17277315, PMID 18441312, PMID 18612117, PMID 18990064, PMID 19383872, PMID 20008710, PMID 20032779, PMID 20332511, PMID 20336198, PMID 20427088, PMID 20580421, PMID 20655123, PMID 20818193, PMID 20876709, PMID 21540423, PMID 21636159, PMID 22417277, PMID 22883509, PMID 22999634, PMID 23129135, PMID 23159553, PMID 23222938, PMID 23613782, PMID 23866070, PMID 24657294, PMID 24680929, PMID 24822048, PMID 24843743

NIH funding

2019 (6), U10EY014231 (6), 2015 (5), U10EY014229 (5), U10EY018817 (5), 2016 (4), 2018 (3), 2023 (3), U24DK122927 (3), 2017 (2), 9SB1EY027241 (2), R44EY026864 (2), 1UG1EY032446 (1), 1UG1EY032446-01 (1), 2008 (1)